Roth Capital Transfers Coverage on Stemline Therapeutics (STML) at Buy May 24, 2019 05:06AM
Stemline Therapeutics Closes $92 Million Public Offering of Common Stock Jan 18, 2019 11:21AM
Stemline Therapeutics (STML) Prices 8.89M Share Upsized Common Offering at $9/Sh Jan 16, 2019 06:12AM
Stemline Therapeutics Announces Upsizing and Pricing of $80 Million Public Offering of Common Stock Jan 15, 2019 10:04PM
Stemline Therapeutics (STML) PT Raised to $33 at Roth Capital Sep 14, 2018 07:41AM


Jun 12, 2018 07:18AM Roth Capital Starts Stemline Therapeutics (STML) at Buy
Jan 26, 2018 10:21AM Stemline Therapeutics Closes $59.6 Million Public Offering of Common Stock
Jan 24, 2018 07:04AM Stemline Therapeutics (STML) Prices 3.7M Share Offering at $14/Sh
Jan 24, 2018 07:00AM Stemline Therapeutics Prices $51.8 Million Public Offering of Common Stock
Jan 20, 2017 09:01AM Stemline Therapeutics (STML) Prices 4.5M Shares at $10
Jan 20, 2017 09:00AM Stemline Therapeutics Prices $45 Million Public Offering of Common Stock
Dec 5, 2016 12:50PM Roth Capital Affirms Stemline Therapeutics (STML) at 'Buy' Following Strong SL-401 Update
Nov 21, 2016 06:47AM Roth Capital Positive on Stemline Therapeutics (STML) Ahead of ASH Amid SL-701 'Surprise'
Nov 8, 2016 12:20PM Streetinsider.com's Hot Lunchtime Reads 11/8: (DEPO) (VRX) (VIPS) (PGNX)
Nov 8, 2016 11:22AM Roth Capital Affirms Stemline Therapeutics (STML) at 'Buy'; Strong Cash Position Noted Ahead of ASH
Aug 23, 2016 09:27AM Roth Capital Reiterates $32 PT on Stemline Therapeutics (STML) as Breakthrough Therapy Granted
Jun 6, 2016 02:33PM Roth Capital Thinks Turning Point Reached on Investment Thesis for Stemline (STML); Affirms at 'Buy'
May 9, 2016 11:43AM Roth Affirms Stemline Therapeutics (STML) at 'Buy'; Focus Now on June ASCO Presentation
Jan 8, 2015 09:06AM Stemline Therapeutics (STML) Prices 3.8M Common Offering at $15.75/Share
Jan 8, 2015 09:05AM Stemline Therapeutics Prices $59.85 Million Public Offering of Common Stock
Oct 27, 2014 07:29AM Stemline's (STML) Valuation is Compelling Heading into 'Data-Rich' 2015 - Roth Capital
Jul 28, 2014 10:41AM Roth Affirms 'Buy' Rating on Stemline (STML); Comments on SL-401 News
Jun 27, 2014 09:06AM Roth Capital Remains Positive on Stemline (STML); Management Updates on SL-401, SL-701
May 16, 2014 07:52AM Roth Capital Keeps Stemline (STML) at 'Buy'; Still Plenty to See and Do in 2014
Apr 1, 2014 11:23AM Roth Lifts PT on Stemline (STML) to $62; Sees 'Pivotal' Year in 2014
Jul 30, 2013 07:02AM Roth Capital Starts Stemline Therapeutics (STML) at Buy